Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Sep 16, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amylyx Pharmaceuticals, Inc.
| 40K |
$2.53 | $101,368.00 | +20.68% | 233.46K |
Sep 12
| |||||||
Amylyx Pharmaceuticals, Inc.
| 18.16K |
$6.88 | $124,975.20 | +32.63% | 73.84K |
Aug 23
| |||||||
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Amylyx Pharmaceuticals, Inc.
| 91.18K |
—
|
—
| +67.65% | 225.96K |
Apr 16
| |||||||
Amylyx Pharmaceuticals, Inc.
| -1.79K |
$18.73 | -$33,560.40 | -1.31% | 134.78K |
Mar 5
| |||||||
Amylyx Pharmaceuticals, Inc.
| 40K |
—
|
—
| +35.70% | 152.03K |
Feb 26
| |||||||
Amylyx Pharmaceuticals, Inc.
| -2.72K |
$16.33 | -$44,347.12 | -2.37% | 112.03K |
Jan 9
| |||||||
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 3
| |||||||
Amylyx Pharmaceuticals, Inc.
| 11.07K |
—
|
—
|
∞
| 11.07K |
Oct 31
| |||||||
Amylyx Pharmaceuticals, Inc.
| 18.16K |
$6.88 | $124,975.20 | +20.60% | 106.34K |
Aug 23
| |||||||
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Amylyx Pharmaceuticals, Inc.
|
0
|
$16.91 | -$651,851.20 |
—
| 55.68K |
May 16
| |||||||
Amylyx Pharmaceuticals, Inc.
| 19.48K |
—
|
—
|
∞
| 19.48K |
Jan 6
| |||||||
Amylyx Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Amylyx Pharmaceuticals, Inc.
| 21.67K |
$19.39 | -$812,859.19 | +63.71% | 55.68K |
Mar 16
| |||||||
Amylyx Pharmaceuticals, Inc.
| -10.83K |
$31.89 | -$1,036,459.19 | -31.85% | 23.18K |
Mar 16
| |||||||
Amylyx Pharmaceuticals, Inc.
| 2.66K |
$36.30 | $96,481.25 | +8.06% | 34.01K |
Jan 6
|
Scheduled
| ||||||
Amylyx Pharmaceuticals, Inc.
| 5K |
$6.88 | $34,400.00 | +15.79% | 36.67K |
Dec 30
| |||||||
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 16
| |||||||
Amylyx Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 11
| |||||||
Amylyx Pharmaceuticals, Inc.
| 31.67K |
—
|
—
|
∞
| 31.67K |
Jan 6
| |||||||
Amylyx Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Sage Therapeutics, Inc.
| 1.81K |
$55.10 | $99,734.62 |
∞
| 1.81K |
Jun 16
| |||||||
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Alkermes Plc.
| 21.98K |
$11.74 | $258,080.42 | +31.47% | 91.83K | +1 |
May 14
| ||||||
Alkermes Plc.
| 3.18K |
$20.84 | -$27,571.32 | +4.77% | 69.84K | +1 |
Mar 1
| ||||||
Alkermes Plc.
| 4.11K |
$20.24 | -$34,650.88 | +6.58% | 66.67K | +1 |
Feb 20 - Feb 21
| ||||||
Alkermes Plc.
| 4.3K |
$17.77 | -$36,890.52 | +7.38% | 62.55K | +1 |
Feb 16 - Feb 17
| ||||||
Alkermes Plc.
| 18K |
$11.74 | $234,800.00 | +44.71% | 58.26K | +1 |
Dec 15 - Sep 13
| ||||||
Sage Therapeutics, Inc.
| -1.70K |
$94.47 | -$1,057,840.00 | -40.14% | 2.54K |
May 6 - Aug 15
|
Scheduled
| ||||||
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 5
| |||||||
Sage Therapeutics, Inc.
|
0
|
$85.57 | -$1,226,400.00 |
—
| 4.24K |
May 6
|
Scheduled
| ||||||
Alkermes Plc.
| 3.18K |
$34.44 | -$45,564.12 | +6.83% | 49.72K | +1 |
Mar 1
| ||||||
Alkermes Plc.
| 1.85K |
$33.92 | -$26,186.24 | +4.15% | 46.54K | +1 |
Feb 26
| ||||||
Alkermes Plc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 21
| ||||||
Alkermes Plc.
| 4.4K |
$32.54 | -$64,201.42 | +10.93% | 44.69K | +1 |
Feb 16 - Feb 17
| ||||||
Sage Therapeutics, Inc.
|
0
|
$71.86 | -$944,175.00 |
—
| 4.24K |
Jan 23
|
Scheduled
| ||||||
Alkermes Plc.
| 3.06K |
$34.01 | -$83,154.45 | +8.20% | 40.29K | +1 |
Dec 7
| ||||||
Sage Therapeutics, Inc.
| -765.00 |
—
|
—
| -15.30% | 4.24K |
Aug 22
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.